微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 32.8% | -8.43% | -8.55% | 111/158 | -2.04% | 海创药业 | 99.57% | 行业排名> |
| 2025-06-30 | 35.87% | 1.57% | -3.93% | 105/158 | 14.94% | 海创药业 | 99.52% | 行业排名> |
| 2025-03-31 | 37.33% | 8.47% | 2.6% | 98/158 | 32.08% | 艾力斯 | 96.74% | 行业排名> |
| 2024-12-31 | 36.39% | 15.24% | 1.58% | 106/158 | 51.81% | 首药控股 | 98.96% | 行业排名> |
| 2024-09-30 | 35.82% | 19.67% | 1.44% | 106/158 | 22.66% | 迪哲医药 | 97.73% | 行业排名> |
| 2024-06-30 | 35.31% | 24.36% | 2.59% | 109/158 | 33.21% | 百利天恒 | 97.99% | 行业排名> |
| 2024-03-31 | 34.42% | 31.59% | 9.01% | 109/158 | 51.68% | 百利天恒 | 98.92% | 行业排名> |
| 2023-12-31 | 31.57% | 27.33% | 5.48% | 119/158 | 51.58% | 迈威生物 | 98.93% | 行业排名> |
| 2023-09-30 | 29.93% | 5.97% | 5.42% | 120/158 | 32.59% | 迈威生物 | 99.59% | 行业排名> |
| 2023-06-30 | 28.4% | -0.54% | 8.56% | 123/158 | 38.52% | 迈威生物 | 99.8% | 行业排名> |
| 2023-03-31 | 26.16% | 13.73% | 5.48% | 125/158 | 52.97% | 迈威生物 | 99.46% | 行业排名> |
| 2022-12-31 | 24.8% | 11.64% | -12.21% | 131/158 | 53.83% | 迈威生物 | 99.75% | 行业排名> |
| 2022-09-30 | 28.25% | 15.47% | -1.06% | 120/158 | 6.03% | 迈威生物 | 99.67% | 行业排名> |
| 2022-06-30 | 28.55% | 2% | 28.53% | 121/158 | 21.28% | 迈威生物 | 99.44% | 行业排名> |
| 2021-12-31 | 22.21% | 2.89% | -9.2% | 141/158 | 55.28% | 迈威生物 | 98.57% | 行业排名> |
| 2021-09-30 | 24.46% | 2% | 6.36% | 122/158 | 46.93% | 首药控股 | 99.93% | 行业排名> |
| 2021-03-31 | 23% | 2% | 6.53% | 115/158 | 54.24% | 艾力斯 | 99.41% | 行业排名> |
| 2020-12-31 | 21.59% | 1.71% | 1.71% | 137/158 | -147.15% | 艾力斯 | 98.7% | 行业排名> |
| 2019-12-31 | 21.23% | -15.09% | -15.09% | 129/158 | -1232.32% | 艾力斯 | 99.4% | 行业排名> |
| 2018-12-31 | 25% | 2% | 2% | 122/158 | -209.94% | 首药控股 | 99.94% | 行业排名> |